KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Minority Interest (2020 - 2025)

AbbVie (ABBV) has disclosed Minority Interest for 6 consecutive years, with $42.0 million as the latest value for Q4 2025.

  • Quarterly Minority Interest rose 7.69% to $42.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $42.0 million through Dec 2025, up 7.69% year-over-year, with the annual reading at $42.0 million for FY2025, 7.69% up from the prior year.
  • Minority Interest for Q4 2025 was $42.0 million at AbbVie, down from $43.0 million in the prior quarter.
  • The five-year high for Minority Interest was $45.0 million in Q2 2025, with the low at $23.0 million in Q1 2021.
  • Average Minority Interest over 5 years is $35.0 million, with a median of $35.0 million recorded in 2022.
  • The sharpest move saw Minority Interest skyrocketed 42.11% in 2021, then dropped 8.57% in 2023.
  • Over 5 years, Minority Interest stood at $28.0 million in 2021, then grew by 17.86% to $33.0 million in 2022, then increased by 12.12% to $37.0 million in 2023, then grew by 5.41% to $39.0 million in 2024, then grew by 7.69% to $42.0 million in 2025.
  • According to Business Quant data, Minority Interest over the past three periods came in at $42.0 million, $43.0 million, and $45.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.